T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPL
851
PPL Corp
PPL
$26.8B
| $24.2M | ﹤0.01% |
956,455
-11,287
| -1% | -$323K |
|
|
CSW
852
CSW Industrials
CSW
$5.59B
| $24.2M | ﹤0.01% |
202,141
-1,301,333
| -87% | -$159M |
|
853
Labcorp
LH
$26.2B
| $24.2M | ﹤0.01% |
137,340
-940,958
| -87% | -$193M |
|
854
Ingevity
NGVT
$2.59B
| $24M | ﹤0.01% |
396,073
-55,663
| -12% | -$3.73M |
|
|
ARCE
855
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $23.9M | ﹤0.01% |
2,219,409
-2,010
| -0.1% | -$28.4K |
|
|
VTYX
856
DELISTED
Ventyx Biosciences
VTYX
| $23.9M | ﹤0.01% |
+685,342
| New | +$15.2M |
|
|
DRE
857
DELISTED
Duke Realty Corp.
DRE
| $23.8M | ﹤0.01% |
494,041
+1,748
| +0.4% | +$102K |
|
858
Sun Communities
SUI
$14.6B
| $23.8M | ﹤0.01% |
175,817
+3,509
| +2% | +$555K |
|
859
Flowserve
FLS
$10.3B
| $23.7M | ﹤0.01% |
975,700
-15,302
| -2% | -$463K |
|
860
Fortune Brands Innovations
FBIN
$5.78B
| $23.4M | ﹤0.01% |
510,877
-15,653
| -3% | -$850K |
|
861
Mid-America Apartment Communities
MAA
$15.6B
| $23.4M | ﹤0.01% |
150,691
-1,039
| -0.7% | -$179K |
|
862
TechTarget
TTGT
$277M
| $23.3M | ﹤0.01% |
394,395
-82,387
| -17% | -$5.3M |
|
863
Leidos
LDOS
$17.9B
| $23.2M | ﹤0.01% |
264,907
-2,211,485
| -89% | -$216M |
|
864
AXIS Capital
AXS
$7.3B
| $23M | ﹤0.01% |
468,188
-10,078,465
| -96% | -$534M |
|
|
K
865
DELISTED
Kellanova
K
| $23M | ﹤0.01% |
351,812
-11,794
| -3% | -$811K |
|
866
Five Below
FIVE
$13.4B
| $23M | ﹤0.01% |
166,734
-2,049,058
| -92% | -$269M |
|
867
Dorman Products
DORM
$3.95B
| $22.9M | ﹤0.01% |
278,760
-820,106
| -75% | -$80.8M |
|
868
Texas Pacific Land
TPL
$23.9B
| $22.7M | ﹤0.01% |
115,164
-268,245
| -70% | -$51.7M |
|
869
Amphastar Pharmaceuticals
AMPH
$858M
| $22.7M | ﹤0.01% |
808,731
+645,917
| +397% | +$21.1M |
|
|
XIFR
870
XPLR Infrastructure LP
XIFR
$1.09B
| $22.6M | ﹤0.01% |
312,570
-1,875,722
| -86% | -$150M |
|
871
Kulicke & Soffa
KLIC
$5.01B
| $22.6M | ﹤0.01% |
585,679
+4,517
| +0.8% | +$200K |
|
872
Clorox
CLX
$12.9B
| $22.4M | ﹤0.01% |
174,069
-106,521
| -38% | -$15.4M |
|
873
Clearway Energy Class C
CWEN
$7.02B
| $22.3M | ﹤0.01% |
699,412
+55,459
| +9% | +$2.04M |
|
874
Tradeweb Markets
TW
$22.3B
| $22.1M | ﹤0.01% |
391,502
-9,402,657
| -96% | -$640M |
|
875
Principal Financial Group
PFG
$24.6B
| $21.9M | ﹤0.01% |
303,763
+8,378
| +3% | +$602K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.